European regulators greenlight AZ's Nexium combo

AstraZeneca's ($AZN) Nexium-plus-aspirin combo, dubbed Axanum, got the nod from European regulators. The company says it's working to get the drug onto formularies there as soon as possible. Report

Suggested Articles

After Purdue’s record opioid settlement, more deals could be on the way. But that doesn’t mean all defendants are prepared to go quietly.

Now in their third quarter on the market, Gilead's own Epclusa and Harvoni generics have together grabbed more than 20% of the U.S. hep C market.

Purdue is seeking bankruptcy after inking a $10 billion-plus opioid settlement with thousands of cities and counties, plus two dozen states.